KU startup earns $300K contract to develop cancer-fighting drug technology

KU startup earns $300K contract to develop cancer-fighting drug technology

HylaPharm, founded in 2010, has received a $300,000 Small Business Innovation Research (SBIR) contract to repurpose an existing drug for the treatment of breast cancer. The National Cancer Institute, which is part of the National Institutes of Health

(Visited 4 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.